IDiyas

For the Inventor, By the Inventor

Urawa, Japan

Katsuo Ikezawa

USPTO Granted Patents = 12

Average Co-Inventor Count = 4.1

ph-index = 5

Forward Citations = 79(Granted Patents)


Location History:

  • Urawa, JA (1977)
  • Urawa, JP (1986 - 2001)

Company Filing History:

goldMedal12 out of 324 
 
Tanabe Seiyaku Company, Limited
 patents

Years Active: 1977-2001

Loading Chart...
12 patents (USPTO):Explore Patents
1. 6214996 - Naphthalene derivates, process for the preparation thereof, and intermediates therefor (2001-04-10),
2. 6005106 - Naphthalene derivatives, process for the preparation therof, and (1999-12-21),
3. 5969140 - Naphthalene derivatives, process for the preparation thereof, and (1999-10-19),
4. 5965730 - Pyridine derivatives (1999-10-12),
5. 5342941 - Naphthalene derivatives, processes for preparing the same, and synthetic (1994-08-30),
6. 5190975 - Indan derivatives used for treating thromboses or asthma (1993-03-02),
7. 5047555 - 4-aminophenol derivatives and processes for preparing the same (1991-09-10),
8. 5030652 - Indan derivatives and pharmaceutical preparation thereof (1991-07-09),
9. 4975460 - Indanoxyacetic acid derivatives (1990-12-04),
10. 4963587 - Glycine derivative and pharmaceutical preparation thereof (1990-10-16),
11. 4579854 - Bronchodilating (1986-04-01),
12. 4054659 - 5,7 Dihydroxy-1-(trimethoxybenzyl)-1,2,3,H-tetrahydroisoquinolines and (1977-10-18),

Title: The Innovative Mind of Katsuo Ikezawa: A Journey Through His Patents

Introduction

Katsuo Ikezawa, an accomplished inventor based in Urawa, Japan, has made significant contributions to the field of pharmaceutical chemistry. With 12 patents to his name, Ikezawa stands out for his innovative approaches to creating compounds that address critical health issues.

Latest Patents

His latest patents focus on naphthalene derivatives, which are notable for their potential in treating asthma. These include processes for the preparation of naphthalene derivatives of the formula [I], which exhibit excellent bronchoconstriction inhibitory activity. These compounds not only demonstrate efficacy in pharmaceutical applications but also highlight Ikezawa's commitment to enhancing respiratory health through science. The detailed molecular structure includes various functional groups, such as protected or unprotected hydroxymethyl and lower alkyl, showcasing his intricate understanding of chemical interactions.

Career Highlights

Ikezawa's career is marked by his tenure at Tanabe Seiyaku Company, Limited, where he has been able to merge his innovative ideas with practical applications in the pharmaceutical industry. His work has played a pivotal role in developing new therapies that can improve patient care in respiratory diseases.

Collaborations

In addition to his own accomplishments, Ikezawa has collaborated with fellow researchers such as Takeo Iwakuma and Tatsuzo Ukita. These partnerships have been instrumental in advancing his research and patents, bringing together diverse expertise to tackle complex challenges in pharmacology.

Conclusion

Katsuo Ikezawa's contributions to science through his numerous patents exemplify the impact of dedicated inventors in healthcare. His work not only demonstrates a profound understanding of chemistry but also a commitment to improving the quality of life for individuals suffering from asthma and other respiratory conditions. As he continues to innovate, the future holds promising advancements in pharmaceutical treatments thanks to his ongoing efforts.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…